# Correction: A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients

**Authors:** Chiara Pane, Vincenzo Di Stefano, Nunzia Cuomo, Alessio Sarnataro, Claudia Vinciguerra, Liliana Bevilacqua, Filippo Brighina, Nicasio Rini, Giorgia Puorro, Angela Marsili, Matteo Garibaldi, Laura Fionda, Francesco Saccà

PMC · DOI: 10.1007/s00415-025-13061-9 · Journal of Neurology · 2025-04-29

## Full-text entities

- **Diseases:** myasthenia gravis (MESH:D009157)
- **Chemicals:** eculizumab (MESH:C481642), efgartigimod (MESH:C000718373)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12041099/full.md

---
Source: https://tomesphere.com/paper/PMC12041099